Alnylam Pharmaceuticals
Meaghan Schmieding, MHM, is an accomplished professional with significant experience in the healthcare and life sciences sectors. Currently serving as Director of Launch Excellence at Alnylam Pharmaceuticals since June 2021, Meaghan also held the position of Associate Director in the same division. Prior to Alnylam, Meaghan worked at Slalom as a Senior Consultant and Consultant, focusing on project management for bio-pharmaceutical and marketing initiatives. Additional roles include EHR Project Analyst/Trainer at MetroWest Medical Center, where Meaghan led a major software conversion, and Inpatient Orders Clinical Application Coordinator at Partners HealthCare, facilitating large-scale Epic implementations. Meaghan's early career includes positions at MEDITECH, Town Sports International, Massachusetts General Hospital, and Fish & Richardson P.C. Meaghan holds a Master's Degree in Healthcare Management from New England College of Business and a Bachelor's Degree in Neurobiology from Boston University.
This person is not in any teams
This person is not in any offices
Alnylam Pharmaceuticals
32 followers
Alnylam is the world's leading RNAi therapeutics company and the first and only company to bring an RNAi medicine to market.